Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Depression associated with antiretroviral drug therapy in HIV: case report and overview.

Kaestner F, Anneken K, Mostert C, Reichelt D, Rothermundt M, Evers S, Husstedt IW.

Int J STD AIDS. 2012 Jun;23(6):e14-9. doi: 10.1258/ijsa.2009.009451.

PMID:
22807551
2.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
3.

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Grierson J, Koelmeyer RL, Smith A, Pitts M.

HIV Med. 2011 Oct;12(9):562-9. doi: 10.1111/j.1468-1293.2011.00928.x. Epub 2011 May 9.

4.

Assessment and predictors of antiretroviral adherence in older HIV-infected patients.

Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G.

J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S106-14.

PMID:
12853859
5.

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.

Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, Hirschel B, Bernasconi E, Rickenbach M, Günthard HF, Bucher HC; Swiss HIV Cohort Study..

J Acquir Immune Defic Syndr. 2010 Jun;54(2):197-203. doi: 10.1097/QAI.0b013e3181ca48bf.

PMID:
20035231
6.

[HIV infection and psychiatric symptoms: a common and important combination].

Schadé A, Bierman WF.

Ned Tijdschr Geneeskd. 2010;154:A1140. Dutch.

PMID:
20132573
7.

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, Chanchhaya N, Ferradini L, Balkan S.

Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19.

8.

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Gordillo V, del Amo J, Soriano V, González-Lahoz J.

AIDS. 1999 Sep 10;13(13):1763-9.

PMID:
10509579
9.

Common problems with antiretroviral therapy among three Swedish groups of HIV infected individuals.

Jallow A, Sporrong SK, Walther-Jallow L, Persson PM, Hellgren U, Ericsson O.

Pharm World Sci. 2007 Aug;29(4):422-9. Epub 2007 Feb 27.

PMID:
17333498
10.

Improvements in antiretroviral therapy outcomes over calendar time.

Boyd MA.

Curr Opin HIV AIDS. 2009 May;4(3):194-9. doi: 10.1097/COH.0b013e328329fc8d. Review.

PMID:
19532050
11.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
12.

Clinical and demographic variables related to pain in HIV-infected individuals treated with effective, combination antiretroviral therapy (cART).

Cervia LD, McGowan JP, Weseley AJ.

Pain Med. 2010 Apr;11(4):498-503. doi: 10.1111/j.1526-4637.2010.00802.x. Epub 2010 Mar 4.

PMID:
20210870
13.

Combination antiretroviral therapy.

Domingo P, Vidal F.

Expert Opin Pharmacother. 2011 May;12(7):995-8. doi: 10.1517/14656566.2011.567001. Epub 2011 Mar 24.

PMID:
21434758
14.

Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients.

Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):432-8.

PMID:
15764960
15.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV..

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
16.

Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.

Webb MS, Vanable PA, Carey MP, Blair DC.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):94-105. doi: 10.1521/aeap.2009.21.3_supp.94.

PMID:
19537957
17.

Adherence to antiretroviral therapy: where are we, and where do we go from here?

Wu AW, Ammassari A, Antinori A.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S95-7. No abstract available.

PMID:
12562028
18.

[Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].

Neumann T, Kondratieva J, Eggebrecht H, Wieneke H, Esser S, Bartel T, Erbel R.

Herz. 2005 Sep;30(6):504-9. Review. German.

PMID:
16170681
19.

Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old.

Pardi GR, Nunes AA, Preto R, Canassa PG, Correia D.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):301-3. doi: 10.1097/QAI.0b013e3181b065ee. No abstract available.

PMID:
20118680
20.

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.

Eldred LJ, Wu AW, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):117-25.

PMID:
9637576

Supplemental Content

Support Center